Literature DB >> 16405927

Presence of delta opioid receptors on a subset of hypothalamic gonadotropin releasing hormone (GnRH) neurons.

Federica Pimpinelli1, Marco Parenti, Francesca Guzzi, Flavio Piva, Tomas Hokfelt, Roberto Maggi.   

Abstract

Opioid peptides exert an inhibitory effect on hypothalamic gonadotropin releasing hormone (GnRH) secretion mainly by interacting with mu-opioid receptors. Although a direct role for opioids via delta-opioid receptors (DORs) has been suggested, the presence of these receptors on GnRH neurons has never been demonstrated. In the present study, we determined the distribution of DORs in the basal hypothalamus of rat with special focus on their relation to GnRH neurons. Double-labelling immunofluorescence and confocal microscopy revealed that DORs are exclusively present in a subpopulation of GnRH nerve terminals, with the highest density in the external layer of the median eminence. We then studied the functional characteristics of DORs in an immortalized GnRH-secreting neuronal cell line (GT1-1) known to endogenously express this receptor. Here, pertussis toxin pretreatment abolished the delta-agonist (DPDPE) inhibitory effect on cAMP accumulation. We also analyzed the type of G proteins involved in the signal transduced by the DOR and showed that GT1-1 cells express the inhibitory Go and Gi2 alpha-subunits. However, only Go was down-regulated under chronic DPDPE exposure. Finally, since DOR is expressed postnatally in brain, we compared GnRH neuronal cells immortalized at different developmental stages (the more mature GT1-1 and GT1-7 cells, versus the more immature GN11 cells), evidencing that only mature neurons express DOR. In conclusion, our study indicates that a direct control of opioids via delta-receptors occurs on GnRH neurons and validates the use of GT1 cells to further investigate the nature of the DOR present on GnRH neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405927     DOI: 10.1016/j.brainres.2005.11.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Paternal morphine exposure induces bidirectional effects on cocaine versus opioid self-administration.

Authors:  Fair M Vassoler; Anika M Toorie; Delaney N Teceno; Pankhuri Walia; Deion J Moore; Trevor D Patton; Elizabeth M Byrnes
Journal:  Neuropharmacology       Date:  2019-11-11       Impact factor: 5.250

Review 3.  [Andrology in oncological diseases].

Authors:  T Weberschock; S Grunewald; F Ochsendorf
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

4.  κ-Opioid Receptor Is Colocalized in GnRH and KNDy Cells in the Female Ovine and Rat Brain.

Authors:  Peyton W Weems; Christine F Witty; Marcel Amstalden; Lique M Coolen; Robert L Goodman; Michael N Lehman
Journal:  Endocrinology       Date:  2016-04-11       Impact factor: 4.736

5.  Hypogonadism in male cancer patients.

Authors:  Basil O Burney; Jose M Garcia
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-04-20       Impact factor: 12.910

6.  Cross-Talk between Metabolism and Reproduction: The Role of POMC and SF1 Neurons.

Authors:  Yong Xu; Latrice D Faulkner; Jennifer W Hill
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-04       Impact factor: 5.555

Review 7.  Clinical significance of androgen secretion disorders in men with a malignancy.

Authors:  Pawel J Wiechno; Grazyna M Poniatowska; Wojciech Michalski; Jakub Kucharz; Malgorzata Sadowska; Joanna Jonska-Gmyrek; Karol Nietupski; Joanna Rzymowska; Tomasz Demkow
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.064

Review 8.  Endogenous testosterone and mortality risk.

Authors:  Emily J Meyer; Gary Wittert
Journal:  Asian J Androl       Date:  2018 Mar-Apr       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.